ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-PROPANOATE
Compound with spectra: 1 NMR
![ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-PROPANOATE](/api/compound/5NJKSYIGKMA.png?ph=true&h=300&w=458 "ETHYL_(3-S)-3-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)-(HYDROXY)-PHOSPHINYL]-PROPANOATE")
| SpectraBase Compound ID | 5NJKSYIGKMA |
|---|---|
| InChI | InChI=1S/C18H26NO8P/c1-3-26-16(20)10-12-28(23,24)11-9-15(17(21)25-2)19-18(22)27-13-14-7-5-4-6-8-14/h4-8,15H,3,9-13H2,1-2H3,(H,19,22)(H,23,24)/t15-/m0/s1 |
| InChIKey | RIJGNQGELVWONR-HNNXBMFYSA-N |
| Mol Weight | 415.38 g/mol |
| Molecular Formula | C18H26NO8P |
| Exact Mass | 415.139604 g/mol |
| Enantiomer InChIKey | RIJGNQGELVWONR-OAHLLOKOSA-N |
| Racemate InChIKey | RIJGNQGELVWONR-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
ETHYL_(3-S)-2-[((3-(N-BENZYLOXYCARBONYL)-AMINO-3-METHOXYCARBONYL)-PROPYL)--PHOSPHINYL]-ETHANOATE
KCTPIMKUEBMFIW-UHFFFAOYSA-N
2-(carboxyamino)-4-[(2-chloroethyl)sulfamoyl]butyric acid
N-CARBOXY-L-GLUTAMINE, N-BENZYL p-NITROPHENYL ESTER
(2S)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid 1,1,1,3,3,3-hexafluoropropan-2-yl ester
N-BIS-[(3S)-3-BENZYLOXYCARBONYLAMINO-3-TERT.-BUTYLOXYCARBONYLPROPYL]-GLYCIN-TERT.-BUTYLESTER
6-(N-BENZYLPIPERIDIN-4-YL-2-ETHYLAMIDO)-N-BENZYLOXYCARBONYL-S-ALPHA-AMINO-ADIPIC-ACID-1-ETHYLESTER
O-(1,1-Dimetyhylethyl)-N-[[(phenylmethoxy)carbonyl]-L-tyrosine 1,1-dimethylethyl ester
2-(benzyloxycarbonylamino)-4-nitro-glutaric acid dimethyl ester
Methyl 2-[(benzyloxycarbonyl)amino]-3-phenylbutyrate
| Title | Journal or Book | Year |
|---|---|---|
| A Virtual Screening Hit Reveals New Possibilities for Developing Group III Metabotropic Glutamate Receptor Agonists | Journal of Medicinal Chemistry | 2010 |